Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer

被引：0
|
作者：
Ming Gao
Xia Zhang
Huan Yan
Decong Sun
Xuejiao Yang
Fang Yuan
Yanfang Ju
Lijie Wang
Jinliang Wang
Wei Zhao
Dong Zhang
Lin Li
Xiaoyun Xu
Junxun Ma
Yi Hu
Xiaotao Zhang
机构：
[1] The Fifth Medical Center of PLA General Hospital,Department of Oncology
[2] The First Medical Center of PLA General Hospital,Department of Oncology
[3] The Second Medical Center of PLA General Hospital,Department of Oncology
[4] Beijing Hospital,Department of Oncology
[5] The First Central Hospital of Baoding,Department of Oncology
[6] The Affiliated Qingdao Central Hospital of Qingdao University,Department of Radiation Oncology
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Pralsetinib; RET; Pneumonia; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer
    Gao, Ming
    Zhang, Xia
    Yan, Huan
    Sun, Decong
    Yang, Xuejiao
    Yuan, Fang
    Ju, Yanfang
    Wang, Lijie
    Wang, Jinliang
    Zhao, Wei
    Zhang, Dong
    Li, Lin
    Xu, Xiaoyun
    Ma, Junxun
    Hu, Yi
    Zhang, Xiaotao
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (12)
  • [2] Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer
    Nguyen, Ly
    Monestime, Shanada
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (07) : 527 - 533
  • [3] Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer
    Zhou, Qing
    Zhao, Jun
    Chang, Jianhua
    Wang, Huijie
    Fan, Yun
    Wang, Ke
    Wu, Gang
    Nian, Weiqi
    Sun, Yuping
    Sun, Meili
    Wang, Xiangcai
    Shi, Huaqiu
    Zheng, Xiangqian
    Yao, Sheng
    Qin, Mengmeng
    Shen, Zhenwei
    Yang, Jason
    Wu, Yi-Long
    [J]. CANCER, 2023, 129 (20) : 3239 - 3251
  • [4] Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study
    Griesinger, Frank
    Curigliano, Giuseppe
    Subbiah, Vivek
    Baik, Christina S.
    Tan, Daniel S. W.
    Lee, Dae H.
    Misch, Daniel
    Garralda, Elena
    Kim, Dong-Wan
    van der Wekken, Anthonie J.
    Gainor, Justin F.
    Paz-Ares, Luis
    Liu, Stephen, V
    Kalemkerian, Gregory P.
    Bowles, Daniel W.
    Mansfield, Aaron S.
    Lin, Jessica J.
    Smoljanovic, Vlatka
    Rahman, Ahmadur
    Zalutskaya, Alena
    Louie-Gao, Melinda
    Boral, Andy L.
    Mazieres, Julien
    [J]. FUTURE ONCOLOGY, 2024, 20 (06) : 297 - 306
  • [5] Targeted therapy of RET fusion-positive non-small cell lung cancer
    Shen, Zixiong
    Qiu, Binxu
    Li, Lin
    Yang, Bo
    Li, Guanghu
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] SORAFENIB IN PATIENTS WITH RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER
    Horiike, Atsushi
    Takeuchi, Kengo
    Uenami, Takeshi
    Kawano, Yuko
    Tanimoto, Azusa
    Kaburaki, Kyohei
    Kobayashi, Hiroshi
    Gyotoku, Hiroshi
    Nishizawa, Hironari
    Tambo, Yuichi
    Nakatomi, Katsumi
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Hagiwara, Sachiko
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S898 - S898
  • [7] Small Cell Transformation in a Patient With RET Fusion-Positive Lung Adenocarcinoma on Pralsetinib
    Dimou, Anastasios
    Lo, Ying-Chun
    Merrell, Kenneth W.
    Halling, Kevin C.
    Mansfield, Aaron S.
    [J]. JCO PRECISION ONCOLOGY, 2022, 6
  • [8] RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
    Novello, Silvia
    Califano, Raffaele
    Reinmuth, Niels
    Tamma, Antonella
    Puri, Tarun
    [J]. ONCOLOGIST, 2023, 28 (05): : 402 - 413
  • [9] Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer
    Horiike, Atsushi
    Takeuchi, Kengo
    Uenami, Takeshi
    Kawano, Yuko
    Tanimoto, Azusa
    Kaburaki, Kyohei
    Tambo, Yuichi
    Kudo, Keita
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. LUNG CANCER, 2016, 93 : 43 - 46
  • [10] Analysis of Resistance Mmechanisms to Pralsetinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) from the ARROW Study
    Gainor, J.
    Curigliano, G.
    Doebele, R. C.
    Lin, J. J.
    Ou, S. -H.
    Miller, S.
    Turner, C. D.
    Subbiah, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S5 - S5
12345